Motor Neurone DiseaseSubscribe to Motor Neurone Disease

A new drug delays motor neurone disease progression and improves cognitive and clinical symptoms according to recently released trial results.

The University of Melbourne and its research partners have received a $1 million philanthropic grant via the Motor Neurone Disease Research Institute of Australia, the research arm of MND Australia.